Zenflox-UTI Tablet is a combination pharmaceutical formulation containing Ofloxacin 200 mg and Flavoxate 200 mg, designed for the effective management of urinary tract infections (UTIs) accompanied by dysuria and urinary spasms. Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and transcription. This action is particularly effective against common uropathogens such as Escherichia coli, Proteus species, and Klebsiella pneumoniae. Flavoxate, a urinary antispasmodic agent, alleviates symptoms of bladder discomfort by relaxing the smooth muscle of the urinary tract, reducing urgency, frequency, and pain associated with urinary tract infections. The combined effect of these agents provides both antimicrobial therapy and symptomatic relief, improving patient compliance and treatment outcomes. Zenflox-UTI is indicated for acute uncomplicated urinary tract infections and symptomatic relief of dysuria, urinary frequency, and bladder spasms. It should be administered as prescribed by a healthcare professional, considering potential contraindications such as hypersensitivity to fluoroquinolones or flavoxate, and caution is advised in patients with renal impairment. Adverse effects may include gastrointestinal disturbances, headache, dizziness, and, rarely, tendonitis associated with fluoroquinolones. Patient monitoring and adherence to prescribed dosage are essential for optimal therapeutic efficacy.